ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,410
Diagnostic referrals
1,028
Outstanding pathways
306

Screening pathway

  1. Screening5,410Encounters
  2. Positive finding1,897Documented findings
  3. Referral1,028Diagnostic referrals
  4. Follow-up1,283Diagnostic visits
  5. Outcome722Resolved pathways

Stage totals use different units. Pending pathways: 306. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0606 · EXP-0606Synthetic · Site D

Full participant history through 2027-06-10, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2027-02-28
  4. · Diagnostic referral · EXP-0606-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-11-02
  11. · Follow-up disposition · Resolved · EXP-0606-T-R
  12. · Screening · HPV DNA · Repeat · Prior VIA positive
  13. · Screening result · HPV DNA · HPV not detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0600 · Expanded synthetic participant 0600Site B — Peri-Urban Access Programme
EXP-0601 · Expanded synthetic participant 0601Site C — Rural Outreach Programme
EXP-0602 · Expanded synthetic participant 0602Site A — Urban Referral Hub
EXP-0603 · Expanded synthetic participant 0603Site C — Rural Outreach Programme
EXP-0604 · Expanded synthetic participant 0604Site B — Peri-Urban Access Programme
EXP-0605 · Expanded synthetic participant 0605Site D — Community Engagement Programme
EXP-0606 · Expanded synthetic participant 0606Site D — Community Engagement Programme
EXP-0607 · Expanded synthetic participant 0607Site B — Peri-Urban Access Programme
EXP-0608 · Expanded synthetic participant 0608Site E — Resource-Constrained Navigation Programme
EXP-0609 · Expanded synthetic participant 0609Site D — Community Engagement Programme
EXP-0610 · Expanded synthetic participant 0610Site A — Urban Referral Hub
EXP-0611 · Expanded synthetic participant 0611Site A — Urban Referral Hub
EXP-0612 · Expanded synthetic participant 0612Site E — Resource-Constrained Navigation Programme
EXP-0614 · Expanded synthetic participant 0614Site A — Urban Referral Hub
EXP-0615 · Expanded synthetic participant 0615Site E — Resource-Constrained Navigation Programme
EXP-0616 · Expanded synthetic participant 0616Site D — Community Engagement Programme
EXP-0618 · Expanded synthetic participant 0618Site D — Community Engagement Programme
EXP-0620 · Expanded synthetic participant 0620Site C — Rural Outreach Programme
EXP-0621 · Expanded synthetic participant 0621Site D — Community Engagement Programme
EXP-0622 · Expanded synthetic participant 0622Site D — Community Engagement Programme
EXP-0623 · Expanded synthetic participant 0623Site E — Resource-Constrained Navigation Programme
EXP-0624 · Expanded synthetic participant 0624Site C — Rural Outreach Programme
EXP-0625 · Expanded synthetic participant 0625Site A — Urban Referral Hub
EXP-0626 · Expanded synthetic participant 0626Site B — Peri-Urban Access Programme
EXP-0627 · Expanded synthetic participant 0627Site E — Resource-Constrained Navigation Programme

Programme insights

Encounters by modality

VIA
1968
HPV DNA
2715
Cytology
727

Navigation activity

Barrier documented
930
Contact attempt
1497
Navigation intervention
417
Diagnostic booking
1298
Diagnostic visit
1283

Documented barriers

Contact difficulty
297
Transport difficulty
308
Appointment coordination
325

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.